Change in fair value included in other income (expense) Fair Value, Measurement with Unobservable Inputs Reconciliation, Recurring Basis, Liability, Gain (Loss) Included in Earnings Schedule Of Shares Reserved For Future Issuance Schedule Of Shares Reserved For Future Issuance [Table Text Block] Schedule Of Shares Reserved For Future Issuance Agreement termination advance notice period Revenue from Contract with Customer, Termination Notice, Period Revenue from Contract with Customer, Termination Notice, Period Net income (loss) per share from discontinued operations, diluted (in dollars per share) Income (Loss) from Discontinued Operations and Disposal of Discontinued Operations, Net of Tax, Per Diluted Share Statistical Measurement [Domain] Statistical Measurement [Domain] Number of renewal options Lessee, Operating Lease, Number Of Renewal Options Lessee, Operating Lease, Number Of Renewal Options Research and development (included related party cost of $1,186, $–, $1,186 and $–, respectively) Research and Development Expense Related Party Transaction [Line Items] Related Party Transaction [Line Items] Expiration period (in years) Share-Based Compensation Arrangement by Share-Based Payment Award, Expiration Period Award Type [Domain] Award Type [Domain] Customer A Customer A [Member] Customer A Expected timing of satisfaction Revenue, Remaining Performance Obligation, Expected Timing of Satisfaction, Period Outstanding, end of period (in shares) Outstanding, beginning of period (in shares) Outstanding, end of period (in shares) Share-Based Compensation Arrangement by Share-Based Payment Award, Equity Instruments Other than Options, Nonvested, Number Collaborative Arrangement, Transaction with Party to Collaborative Arrangement Collaborative Arrangement, Transaction with Party to Collaborative Arrangement [Member] Number of votes per common stock Number Of Votes Per Common Share Number Of Votes Per Common Share Option, maximum purchase amount (in shares) Option Indexed to Issuer's Equity, Shares Statement of Stockholders' Equity [Abstract] Statement of Stockholders' Equity [Abstract] Discount rate (in percent) Sale Of Stock, Discount Rate, Percentage Sale Of Stock, Discount Rate, Percentage Cash, Cash Equivalents and Investments Cash, Cash Equivalents and Investments [Table Text Block] Spark Spark [Member] Spark Performance Shares Performance Shares [Member] Accounts payable Accounts Payable, Current Vested and exercisable, Weighted average remaining contractual life (Years) Share-Based Compensation Arrangement by Share-Based Payment Award, Options, Exercisable, Weighted Average Remaining Contractual Term Conversion of redeemable convertible preferred stock into common stock in connection with the Reverse Recapitalization, net of transaction cost (in shares) Temporary Equity, Shares, Conversion Of Convertible Securities Temporary Equity, Shares, Conversion Of Convertible Securities Corporate debt securities Corporate Debt Securities [Member] Fair value of asset Beginning balance Ending balance Fair Value, Measurement with Unobservable Inputs Reconciliation, Recurring Basis, Asset Value Total other income (expense), net Nonoperating Income (Expense) Commitments and contingencies (Note 12) Commitments and Contingencies Lessee, Operating Lease, Liability, Payment, Due [Abstract] Lessee, Operating Lease, Liability, to be Paid, Fiscal Year Maturity [Abstract] Expected share price volatility Measurement Input, Price Volatility [Member] Vested and exercisable (in shares) Share-Based Compensation Arrangement by Share-Based Payment Award, Options, Exercisable, Number Disaggregation of Revenue [Line Items] Disaggregation of Revenue [Line Items] Long-term purchase commitment amount Long-Term Purchase Commitment, Amount Sale of stock, issuance costs Sale Of Stock, Issuance Costs Sale Of Stock, Issuance Costs Stockholders’ Equity Equity [Text Block] Collaborative Arrangement and Arrangement Other than Collaborative [Axis] Collaborative Arrangement and Arrangement Other than Collaborative [Axis] Income Tax Income Tax Disclosure [Text Block] Organization and Description of Business Business Description and Basis of Presentation [Text Block] Deferred revenue Increase (Decrease) in Contract with Customer, Liability Dividend yield (in percent) Share-Based Compensation Arrangement by Share-Based Payment Award, Fair Value Assumptions, Expected Dividend Rate Sublease income Operating Lease, Lease Income, Lease Payments Concentration Risk [Line Items] Concentration Risk [Line Items] Long-Term Purchase Commitment, Category of Item Purchased [Domain] Long-Term Purchase Commitment, Category of Item Purchased [Domain] Customer [Axis] Customer [Axis] Preferred stock, par value per share (in dollars per share) Preferred Stock, Par or Stated Value Per Share Preferred stock, $0.0001 par value; 10,000,000 shares authorized at September 30, 2023 and December 31, 2022; zero shares issued and outstanding at September 30, 2023 and December 31, 2022, respectively Preferred Stock, Value, Issued Subsequent Event Type [Domain] Subsequent Event Type [Domain] Weighted-Average Exercise Price Weighted-Average Grant Date Fair Value Share-Based Compensation Arrangement by Share-Based Payment Award, Equity Instruments Other than Options, Nonvested, Weighted Average Grant Date Fair Value [Abstract] Terms of award (in years) Share-Based Compensation Arrangement by Share-Based Payment Award, Terms of Award Number of contingent earnout shares per tranche (in shares) Reverse Recapitalization, Contingent Consideration, Equity, Shares per Tranche Reverse Recapitalization, Contingent Consideration, Equity, Shares per Tranche Shares issued in transaction, threshold (as a percent) Sale Of Stock, Shares Issued In Transaction, Threshold, Percent Sale Of Stock, Shares Issued In Transaction, Threshold, Percent Computer equipment and software Computer Equipment and Software [Member] Computer Equipment and Software Net loss per share, diluted (in dollars per share) Net loss per share attributable to common stockholders, diluted (in shares) Earnings Per Share, Diluted Term of agreement (in years) Research and Development Expense, Term of Agreement Research and Development Expense, Term of Agreement BlueRock BlueRock [Member] BlueRock Property, Plant and Equipment [Table] Property, Plant and Equipment [Table] Accounts receivable Accounts Receivable, after Allowance for Credit Loss, Current Lessor, Operating Lease, Payment to be Received, Fiscal Year Maturity [Abstract] Lessor, Operating Lease, Payment to be Received, Fiscal Year Maturity [Abstract] Term (in years) Reverse Recapitalization, Contingent Consideration, Equity, Term Reverse Recapitalization, Contingent Consideration, Equity, Term Fair Value, Inputs, Level 3 Fair Value, Inputs, Level 3 [Member] Outstanding, beginning of period (in shares) Share-Based Compensation Arrangement by Share-Based Payment Award, Options, Outstanding, Number Thereafter Lessee, Operating Lease, Liability, to be Paid, After Year Four Lessee, Operating Lease, Liability, to be Paid, After Year Four Interest income accrued and not received Interest Income Accrued And Not Received Interest Income Accrued And Not Received Employment offer, number of employees Employment Offer, Number Of Employees Employment Offer, Number Of Employees Exercise of common stock options Stock Issued During Period, Value, Stock Options Exercised Trading Symbol Trading Symbol U.S. agency securities US Government Agencies Debt Securities [Member] Granted (in dollars per share) Share-Based Compensation Arrangements by Share-Based Payment Award, Options, Grants in Period, Weighted Average Exercise Price Schedule of Prepaid Expenses and Other Current Assets Schedule of Other Current Assets [Table Text Block] Weighted average grant date fair value of options granted (in dollars per share) Share-Based Compensation Arrangement by Share-Based Payment Award, Options, Grants in Period, Weighted Average Grant Date Fair Value Unrealized gain (loss) on investments OCI, Debt Securities, Available-for-Sale, Gain (Loss), after Adjustment, Tax Net loss Net loss Net loss Net loss Net Income (Loss) Total current liabilities Liabilities, Current Derivative Contract [Domain] Derivative Contract [Domain] Fair Value Disclosures [Abstract] Number of shares issued, threshold (in shares) Sale Of Stock, Number Of Shares Issued In Transaction, Threshold Sale Of Stock, Number Of Shares Issued In Transaction, Threshold Operating Leases Lessee, Operating Leases [Text Block] Liabilities and Stockholders’ Equity Liabilities and Equity [Abstract] Entity Ex Transition Period Entity Ex Transition Period Total undiscounted sublease payments Lessor, Operating Lease, Payment to be Received Employee Stock Employee Stock [Member] Stockholders’ equity: Equity, Attributable to Parent [Abstract] Concentration Risk Benchmark [Domain] Concentration Risk Benchmark [Domain] Contract assets, cumulative catch-up adjustments Contract with Customer, Asset, Cumulative Catch-up Adjustment to Revenue, Modification of Contract Unrealized Loss Debt Securities, Available-for-Sale, Accumulated Gross Unrealized Loss, before Tax Upfront payment under research collaboration and license agreement Contract with Customer, Liability Exercise of common stock options (in shares) Share-Based Compensation Arrangement by Share-Based Payment Award, Options, Exercises in Period Schedule of Earnings Per Share, Basic and Diluted Schedule of Earnings Per Share, Basic and Diluted [Table Text Block] Related party transaction, amount of transaction Related Party Transaction, Amounts of Transaction Vesting period (in years) Share-Based Compensation Arrangement by Share-Based Payment Award, Award Vesting Period Fair Value, Assets Measured on Recurring Basis, Unobservable Input Reconciliation Fair Value, Assets Measured on Recurring Basis, Unobservable Input Reconciliation [Table Text Block] 2027 Lessor, Operating Lease, Payment to be Received, Year Four Net Cash Provided by (Used in) Discontinued Operations [Abstract] Net Cash Provided by (Used in) Discontinued Operations [Abstract] Number of Options Number of Restricted Stock Units Share-Based Compensation Arrangement by Share-Based Payment Award, Equity Instruments Other than Options, Nonvested, Number of Shares [Roll Forward] Summary of Significant Accounting Policies Significant Accounting Policies [Text Block] Maximum proceeds purchase agreement Sale Of Stock, Maximum Amount Authorized Sale Of Stock, Maximum Amount Authorized Level 1 Fair Value, Inputs, Level 1 [Member] Purchases of property and equipment in accounts payable and accrued expenses Discontinued Operation, Payments to Acquire Property, Plant, and Equipment In Accounts Payable And Accrued Expenses Discontinued Operation, Payments to Acquire Property, Plant, and Equipment In Accounts Payable And Accrued Expenses Purchases of short-term investments Payments to Acquire Short-Term Investments Schedule of Property and Equipment, Net Property, Plant and Equipment [Table Text Block] Equity Components [Axis] Equity Components [Axis] Financial Instruments [Domain] Financial Instruments [Domain] General and administrative Disposal Group, Including Discontinued Operation, Genera And Administrative Expense, Net Of Reversals Disposal Group, Including Discontinued Operation, Genera And Administrative Expense, Net Of Reversals Lessee, Lease, Description [Table] Lessee, Lease, Description [Table] Granted (in shares) Share-Based Compensation Arrangement by Share-Based Payment Award, Options, Grants in Period, Gross Entity Small Business Entity Small Business Contingent Consideration by Type [Axis] Contingent Consideration by Type [Axis] Local Phone Number Local Phone Number Accounts receivable Increase (Decrease) in Accounts Receivable Schedule of Business Acquisitions by Acquisition, Contingent Consideration [Table] Schedule of Business Acquisitions by Acquisition, Contingent Consideration [Table] Operating lease liabilities, net of current portion Operating Lease, Liability, Noncurrent Costs Incurred On Behalf Of GeneFab Costs Incurred On Behalf Of GeneFab [Member] Costs Incurred On Behalf Of GeneFab Restricted Stock Units (RSUs) Restricted Stock Units (RSUs) [Member] Debt Instrument, Name [Domain] Debt Instrument, Name [Domain] Fair Value Measurement Inputs and Valuation Techniques [Table] Fair Value Measurement Inputs and Valuation Techniques [Table] Other income (expense) Disposal Group, Including Discontinued Operation, Other Income (Expense) Disposal Group, Including Discontinued Operation, Other Income (Expense) Depreciation Depreciation Gain recognized on fair value of embedded derivative on SPAC merger date Adjustments To Additional Paid In Capital, Gain On Embedded Derivative Adjustments To Additional Paid In Capital, Gain On Embedded Derivative Contingent consideration receivable, measurement input Contingent Consideration, Asset, Measurement Input Contingent Consideration, Asset, Measurement Input GeneFab Economic Share GeneFab Economic Share [Member] GeneFab Economic Share Income Statement Location [Axis] Income Statement Location [Axis] Collaborative Arrangement and Arrangement Other than Collaborative [Domain] Collaborative Arrangement and Arrangement Other than Collaborative [Domain] Income Statement, Balance Sheet and Additional Disclosures by Disposal Groups, Including Discontinued Operations [Line Items] Income Statement, Balance Sheet and Additional Disclosures by Disposal Groups, Including Discontinued Operations [Line Items] Vested and exercisable, end of period, weighted average remaining contractual life (in years) Share-Based Compensation Arrangement By Share-Based Payment Award, Equity Instruments Other Than Options, Vested And Exercisable, Weighted Average Remaining Contractual Term Share-Based Compensation Arrangement By Share-Based Payment Award, Equity Instruments Other Than Options, Vested And Exercisable, Weighted Average Remaining Contractual Term Lessee, Operating Lease, Liability, Maturity Lessee, Operating Lease, Liability, to be Paid, Maturity [Table Text Block] 2022 Inducement Equity Plan 2022 Inducement Equity Plan [Member] 2022 Inducement Equity Plan Contingent Consideration, Tranche One Contingent Consideration, Tranche One [Member] Contingent Consideration, Tranche One Maximum contingent earnout (in shares) Reverse Recapitalization, Contingent Consideration, Equity, Shares Reverse Recapitalization, Contingent Consideration, Equity, Shares Additional Reverse Recapitalization transaction costs Adjustments to Additional Paid in Capital, Stock Issued, Issuance Costs Number of trading days Reverse Recapitalization, Contingent Consideration, Equity, Earnout Period, Threshold Trading Days Reverse Recapitalization, Contingent Consideration, Equity, Earnout Period, Threshold Trading Days Number of shares issued (in shares) Sale of Stock, Number of Shares Issued in Transaction Changes in assets and liabilities: Increase (Decrease) in Operating Assets [Abstract] Total revenue Revenues Risk-free interest rate Measurement Input, Risk Free Interest Rate [Member] Fair Value by Liability Class [Domain] Fair Value by Liability Class [Domain] Product and Service [Domain] Product and Service [Domain] Schedule of Antidilutive Securities Excluded from Computation of Earnings Per Share Schedule of Antidilutive Securities Excluded from Computation of Earnings Per Share [Table Text Block] Schedule of Accrued Expenses and Other Liabilities Schedule of Accounts Payable and Accrued Liabilities [Table Text Block] Beginning balance Ending balance Temporary Equity, Carrying Amount, Attributable to Parent Lease, Cost Lease, Cost [Table Text Block] Research and development Research and Development Expense [Member] Cash flows from investing activities Investing activities: Net Cash Provided by (Used in) Investing Activities [Abstract] Change in fair value Change in fair value Fair Value, Option, Changes in Fair Value, Gain (Loss) Total Antidilutive Securities Excluded from Computation of Earnings Per Share, Amount Award Type [Axis] Award Type [Axis] Grants in period (in shares) Share-Based Compensation Arrangement by Share-Based Payment Award, Equity Instruments Other than Options, Grants in Period offering period (in months) Share-Based Compensation Arrangement By Share-based Payment Award, Offering Period Share-Based Compensation Arrangement By Share-based Payment Award, Offering Period Plan Name [Domain] Plan Name [Domain] Document Quarterly Report Document Quarterly Report Supplemental disclosures of noncash financing and investing items Supplemental disclosures of noncash investing items: Noncash Investing and Financing Items [Abstract] Cost not yet recognized, excluding options Share-Based Payment Arrangement, Nonvested Award, Excluding Option, Cost Not yet Recognized, Amount Purchases of property and equipment in accounts payable and accrued expenses Capital Expenditures Incurred but Not yet Paid Expected costs and expenses incurred Research and Development Arrangement, Expected Costs Research and Development Arrangement, Expected Costs Fair Value Hierarchy and NAV [Domain] Fair Value Hierarchy and NAV [Domain] Other Financial Statement information Additional Financial Information Disclosure [Text Block] Gain on extinguishment of convertible notes Gain on extinguishment of convertible notes Gain (Loss) on Extinguishment of Debt General and administrative General and Administrative Expense [Member] Authorized for issuance under share-based payment arrangement (in shares) Share-Based Compensation Arrangement by Share-Based Payment Award, Number of Shares Authorized Property and equipment at cost Property, Plant and Equipment, Gross Outstanding, beginning of period, Weighted average remaining contractual life (Years) Outstanding, end of period, Weighted average remaining contractual life (Years) Share-Based Compensation Arrangement by Share-Based Payment Award, Options, Outstanding, Weighted Average Remaining Contractual Term GeneFab Transaction Related Parties Related Party Transactions Disclosure [Text Block] Less imputed interest Lessee, Operating Lease, Liability, Undiscounted Excess Amount Lab Automation Equipment Purchase Lab Automation Equipment Purchase [Member] Lab Automation Equipment Purchase Use of Estimates Use of Estimates, Policy [Policy Text Block] Entity File Number Entity File Number Schedule of Antidilutive Securities Excluded from Computation of Earnings Per Share [Table] Schedule of Antidilutive Securities Excluded from Computation of Earnings Per Share [Table] Purchase price, threshold Sale of Stock, Daily Amount To Be Sold, Threshold Sale of Stock, Daily Amount To Be Sold, Threshold 2022 Stock Incentive Plan 2022 Stock Incentive Plan [Member] 2022 Stock Incentive Plan Prepaid expenses (including prepaid rent) Prepaid Expense, Current Discount rate Measurement Input, Discount Rate [Member] Operating lease liabilities Operating Lease, Liability, Current License License [Member] Issuance of common stock under Employee Stock Purchase Plan (ESPP) (in shares) Stock Issued During Period, Shares, Employee Stock Purchase Plans Fair Value, Liabilities Measured on Recurring Basis, Unobservable Input Reconciliation [Line Items] Fair Value, Liabilities Measured on Recurring Basis, Unobservable Input Reconciliation [Line Items] Entity Shell Company Entity Shell Company 2026 Lessee, Operating Lease, Liability, to be Paid, Year Three Property, Plant and Equipment [Line Items] Property, Plant and Equipment [Line Items] Recent Accounting Standards New Accounting Pronouncements, Policy [Policy Text Block] Grant income Revenue Not from Contract with Customer Revenue Revenue From and Not From Contracts [Text Block] Revenue From and Not From Contracts Stock-based compensation expense from discontinued operations Disposal Group, Including Discontinued Operation, Share-Based Payment Arrangement Expense Disposal Group, Including Discontinued Operation, Share-Based Payment Arrangement Expense Early exercise liability, current portion Early Exercise Liability, Current Early Exercise Liability, Current Counterparty Name [Domain] Counterparty Name [Domain] Cash, cash equivalents, and restricted cash, beginning of period Cash, cash equivalents, and restricted cash, end of period Total cash, cash equivalents and restricted cash Cash, cash equivalents, and restricted cash Cash, Cash Equivalents, Restricted Cash, and Restricted Cash Equivalents Asset Class [Axis] Asset Class [Axis] 2025 Lessee, Operating Lease, Liability, to be Paid, Year Two Expected term (years) Measurement Input, Expected Term [Member] Variable lease cost Variable Lease, Cost Operating lease cost Operating Lease, Cost Common stock, shares issued (in shares) Common Stock, Shares, Issued Notes receivable at fair value Notes Receivable, Fair Value Disclosure Vested and exercisable, end of period (in shares) Share-Based Compensation Arrangement by Share-Based Payment Award, Equity Instruments Other than Options, Vested in Period Deferred revenue Contract with Customer, Liability, Current Schedule of Share-Based Payment Award, Stock Options, Valuation Assumptions Schedule of Share-Based Payment Award, Stock Options, Valuation Assumptions [Table Text Block] Security Exchange Name Security Exchange Name Aggregate purchase price Sale of Stock, Consideration Received on Transaction Accumulated other comprehensive income Accumulated Other Comprehensive Income (Loss), Net of Tax Award vesting rights (in percent) Share-Based Compensation Arrangement by Share-Based Payment Award, Award Vesting Rights, Percentage Options Employee Stock Option [Member] Cash acquired through reverse recapitalization Cash Acquired Through Reverse Recapitalization Cash Acquired Through Reverse Recapitalization Common Class A Common Class A [Member] Cost not yet recognized, period for recognition (in years) Share-Based Payment Arrangement, Nonvested Award, Cost Not yet Recognized, Period for Recognition Maximum Maximum [Member] Comprehensive loss Comprehensive Income (Loss), Net of Tax, Attributable to Parent Document Type Document Type Seer, Inc. Seer, Inc. [Member] Seer, Inc. Stock-based compensation Discontinued Operation, Share-Based Payment Arrangement, Noncash Expense Discontinued Operation, Share-Based Payment Arrangement, Noncash Expense Short-term lease cost Short-Term Lease, Cost Net income (loss) per share from discontinued operations, basic (in dollars per share) Income (Loss) from Discontinued Operations and Disposal of Discontinued Operations, Net of Tax, Per Basic Share Cash and cash equivalents and debt securities, available-for-sale, fair value Cash, Cash Equivalents, Restricted Cash And Debt Securities, Available-For-Sale, Fair Value Cash, Cash Equivalents, Restricted Cash And Debt Securities, Available-For-Sale, Fair Value Contingent earnout liability recognized upon closing of the Reverse Recapitalization Adjustments to Additional Paid in Capital, Contingent Consideration Liability on Closing of the Reverse Recapitalization Adjustments to Additional Paid in Capital, Contingent Consideration Liability on Closing of the Reverse Recapitalization Entity Address, Address Line One Entity Address, Address Line One Antidilutive Securities, Name [Domain] Antidilutive Securities, Name [Domain] Subsequent Event [Table] Subsequent Event [Table] Stock-Based Compensation Share-Based Payment Arrangement [Text Block] Basis of Presentation Basis of Accounting, Policy [Policy Text Block] Current stock price Measurement Input, Share Price [Member] Weighted-Average Exercise Price Share-Based Compensation Arrangement by Share-Based Payment Award, Options, Outstanding, Weighted Average Exercise Price [Abstract] 2023, for the remainder of the year Lessor, Operating Lease, Payment to be Received, Remainder of Fiscal Year Fair Value, Liabilities Measured on Recurring Basis, Unobservable Input Reconciliation [Table] Fair Value, Liabilities Measured on Recurring Basis, Unobservable Input Reconciliation [Table] Subsequent Event Subsequent Event [Member] Vesting of early exercise of common stock options Stock Issued During Period, Value, Vesting Of Early Exercise Of Stock Options Stock Issued During Period, Value, Vesting Of Early Exercise Of Stock Options Customer Concentration Risk Customer Concentration Risk [Member] Income Statement [Abstract] 2024 Lessor, Operating Lease, Payment to be Received, Year One Deposits Deposits Assets, Current Long-Term Purchase Commitment [Table] Long-Term Purchase Commitment [Table] Issuance of common stock upon Reverse Recapitalization, net of transaction costs (in shares) Stock Issued During Period, Shares, New Issues Forfeited (in shares) Share-Based Compensation Arrangement by Share-Based Payment Award, Options, Forfeitures in Period Title of 12(b) Security Title of 12(b) Security Loss from discontinued operations Disposal Group, Including Discontinued Operation, Operating Income (Loss) GeneFab sublease income - related party Sublease Income Related Party [Domain] Related Party, Type [Domain] Derivative liability Derivative Liability Outstanding, beginning of period (in dollars per share) Outstanding, end of period (in dollars per share) Share-Based Compensation Arrangement by Share-Based Payment Award, Equity Instruments Other than Options, Nonvested, Weighted Average Grant Date Fair Value Measurement Input, Equity Value Measurement Input, Equity Value [Member] Measurement Input, Equity Value Other Other Assets, Current Class of Stock [Line Items] Class of Stock [Line Items] Income Tax Disclosure [Abstract] Share-Based Payment Arrangement [Abstract] Entity Tax Identification Number Entity Tax Identification Number Option, installments, percentage of stock outstanding (in percent) Option Indexed to Issuer's Equity, Shares, Per Installment, Percentage Of Stock Outstanding Option Indexed to Issuer's Equity, Shares, Per Installment, Percentage Of Stock Outstanding Total lease cost Lease, Cost Total operating expenses Disposal Group, Including Discontinued Operation, Operating Expense Statistical Measurement [Axis] Statistical Measurement [Axis] Balance Sheet Location [Domain] Balance Sheet Location [Domain] Financial Instrument [Axis] Financial Instrument [Axis] Operating Activities [Domain] Operating Activities [Domain] Entity Interactive Data Current Entity Interactive Data Current Disaggregation of Revenue [Table] Disaggregation of Revenue [Table] Earnings Per Share Earnings Per Share, Basic and Diluted EPS [Abstract] Earnings Per Share, Basic and Diluted EPS Debt Securities, Available-for-Sale [Table] Debt Securities, Available-for-Sale [Table] Adjustments to reconcile net loss to net cash used in operating activities: Adjustments, Noncash Items, to Reconcile Net Income (Loss) to Cash Provided by (Used in) Operating Activities [Abstract] Property and equipment, net Disposal Group, Including Discontinued Operation, Property, Plant and Equipment Reconciliation of cash, cash equivalents and restricted cash Cash, Cash Equivalents, Restricted Cash, and Restricted Cash Equivalents [Abstract] Entity Common Stock, Shares Outstanding Entity Common Stock, Shares Outstanding Issuance of common stock for Common Stock Purchase Agreement fee Stock Issued for Purchase Agreement Fee Stock Issued for Purchase Agreement Fee Expenses incurred from transaction, payment term (in years) Related Party Transaction, Payment Term Related Party Transaction, Payment Term Fair value of contingent earnout shares Contingent Consideration Classified as Equity, Fair Value Disclosure Share-Based Compensation Arrangement by Share-Based Payment Award [Line Items] Share-Based Compensation Arrangement by Share-Based Payment Award [Line Items] Fair Value Hierarchy and NAV [Axis] Fair Value Hierarchy and NAV [Axis] Accumulated deficit Retained earnings (accumulated deficit) Retained Earnings (Accumulated Deficit) Commitments and Contingencies Disclosure [Abstract] Principal amount of unsecured convertible promissory note Debt Instrument, Face Amount Annual increase in authorized shares, percentage Share-Based Compensation Arrangement by Share-Based Payment Award, Annual Increase In Authorized Shares, Percentage Share-Based Compensation Arrangement by Share-Based Payment Award, Annual Increase In Authorized Shares, Percentage Entity Incorporation, State or Country Code Entity Incorporation, State or Country Code Leases [Abstract] Accrued expenses and other current liabilities Total accrued expenses and other current liabilities Accounts Payable and Other Accrued Liabilities, Current Business Acquisition, Contingent Consideration [Line Items] Business Acquisition, Contingent Consideration [Line Items] Assets sold Disposal Group, Including Discontinued Operation, Assets Entity Address, State or Province Entity Address, State or Province Counterparty Name [Axis] Counterparty Name [Axis] GeneFab Note Receivable GeneFab Note Receivable [Member] GeneFab Note Receivable GeneFab Option Derivatives, Policy [Policy Text Block] Operating activities (noncash adjustments to net income): Net Cash Provided by (Used in) Operating Activities [Abstract] Antidilutive Securities Excluded from Computation of Earnings Per Share [Line Items] Antidilutive Securities Excluded from Computation of Earnings Per Share [Line Items] Net loss per share from continuing operations, basic (in dollars per share) Income (Loss) from Continuing Operations, Per Basic Share Schedule of Related Party Transactions, by Related Party [Table] Schedule of Related Party Transactions, by Related Party [Table] Variable consideration Revenue, Remaining Performance Obligation, Variable Consideration Amount Revenue, Remaining Performance Obligation, Variable Consideration Amount Unrealized loss on investments OCI, Debt Securities, Available-for-Sale, Gain (Loss), after Adjustment and Tax Common stock, shares outstanding (in shares) Beginning balance (in shares) Ending balance (in shares) Common Stock, Shares, Outstanding Trading volume available for purchase, threshold (in percent) Sale Of Stock, Daily Trading Volume Available For Purchase, Threshold, Percent Sale Of Stock, Daily Trading Volume Available For Purchase, Threshold, Percent Depreciation Depreciation and Amortization, Discontinued Operations Disposal Group Name [Domain] Disposal Group Name [Domain] Lessor, Operating Lease, Payment to be Received, Maturity Lessor, Operating Lease, Payment to be Received, Maturity [Table Text Block] Period of recognition of grant (in years) Grant Assistance, Period Of Recognition Grant Assistance, Period Of Recognition Other non-cash charges Other Operating Activities, Cash Flow Statement Increase (Decrease) in Temporary Equity [Roll Forward] Increase (Decrease) in Temporary Equity [Roll Forward] Asset Class [Domain] Asset Class [Domain] Common stock, par or stated value (in dollars per share) Common Stock, Par or Stated Value Per Share Sale of Stock [Axis] Sale of Stock [Axis] Accrued professional and service fees other Accrued Professional Fees, Other, Current Accrued Professional Fees, Other, Current Class of Stock [Domain] Class of Stock [Domain] Net cash from investing activities Net Cash Provided by (Used in) Investing Activities Customer [Domain] Customer [Domain] Number of Options Share-Based Compensation Arrangement by Share-Based Payment Award, Options, Outstanding [Roll Forward] Debt Instrument [Axis] Debt Instrument [Axis] Disposal Group, Including Discontinued Operation, Balance Sheet Disclosures [Abstract] Disposal Group, Including Discontinued Operation, Balance Sheet Disclosures [Abstract] Net loss from continuing operations Net loss from continuing operations Income (Loss) from Continuing Operations, Net of Tax, Attributable to Parent Thereafter Lessor, Operating Lease, Payment to be Received, after Year Four Lessor, Operating Lease, Payment to be Received, after Year Four GeneFab Option - related party Derivative Liability, Noncurrent Total lease liabilities Operating Lease, Liability Other long-term assets Disposal Group, Including Discontinued Operation, Other Assets, Noncurrent Measurement Input Type [Domain] Measurement Input Type [Domain] Measurement input Business Combination, Contingent Consideration Classified as Equity, Measurement Input Business Combination, Contingent Consideration Classified as Equity, Measurement Input Total liabilities Liabilities Expected volatility (in percent) Share-Based Compensation Arrangement by Share-Based Payment Award, Fair Value Assumptions, Expected Volatility Rate Share-Based Payment Arrangement, Expensed and Capitalized, Amount [Line Items] Share-Based Payment Arrangement, Expensed and Capitalized, Amount [Line Items] Disposal Group, Including Discontinued Operation, Consideration Disposal Group, Including Discontinued Operation, Consideration Prepaid expenses and other assets Increase (Decrease) in Prepaid Expense and Other Assets Accumulated Other Comprehensive Income AOCI Attributable to Parent [Member] Revenue, Remaining Performance Obligation, Expected Timing of Satisfaction, Start Date [Axis] Revenue, Remaining Performance Obligation, Expected Timing of Satisfaction, Start Date [Axis] Contingent Consideration Tranches [Axis] Contingent Consideration Tranches [Axis] Contingent Consideration Tranches Cash, cash equivalents, and short-term investments Cash, Cash Equivalents, and Short-Term Investments Common stock reserved for future issuance (in shares) Common Stock, Capital Shares Reserved for Future Issuance 2026 Lessor, Operating Lease, Payment to be Received, Year Three Disposal Groups, Including Discontinued Operations [Table] Disposal Groups, Including Discontinued Operations [Table] Tenant improvement allowance remaining Tenant Improvement Allowance, Remaining Amount Tenant Improvement Allowance, Remaining Amount Operating Activities [Axis] Operating Activities [Axis] Plan Name [Axis] Plan Name [Axis] Related Party Transaction [Domain] Related Party Transaction [Domain] Alameda Alameda [Member] Alameda Long-Lived Tangible Asset [Domain] Long-Lived Tangible Asset [Domain] Number of consecutive trading days Reverse Recapitalization, Contingent Consideration, Equity, Earnout Period, Threshold Consecutive Trading Days Reverse Recapitalization, Contingent Consideration, Equity, Earnout Period, Threshold Consecutive Trading Days Number of reportable segments Number of Reportable Segments Earnings Per Share [Abstract] Subsequent Event [Line Items] Subsequent Event [Line Items] Common stock, $0.0001 par value; 500,000,000 shares authorized at September 30, 2023 and December 31, 2022; 44,477,666 and 44,062,534 shares issued and outstanding at September 30, 2023 and December 31, 2022, respectively Common Stock, Value, Issued Contingent earnout common stock Contingent Earnout Common Stock [Member] Contingent Earnout Common Stock General and administrative General and Administrative Expense Organization, Consolidation and Presentation of Financial Statements [Abstract] Discontinued Operations Discontinued Operations [Member] Accrued professional and service fees related to facility construction Accrued Professional Fees, Current Amortization of operating lease right-of-use assets Operating Lease, Right-of-Use Asset, Periodic Reduction Contingent Consideration Receivable Contingent Consideration, Asset [Member] Contingent Consideration, Asset Fair value of contingent earnout shares Reverse Recapitalization, Contingent Consideration, Fair Value Reverse Recapitalization, Contingent Consideration, Fair Value Total current assets Assets, Current Notes receivable, measurement input Notes Receivable, Measurement Input Notes Receivable, Measurement Input Principal finance lease payments Finance Lease, Principal Payments Impairment of property and equipment Asset Impairment Charges Contingent consideration, liability Business Combination, Contingent Consideration, Liability Restricted cash Restricted Cash Share-Based Payment Arrangement, Outstanding Award, Activity, Excluding Option Share-Based Payment Arrangement, Outstanding Award, Activity, Excluding Option [Table Text Block] GeneFab sublease deferred income - related party Increase (Decrease) In Deferred Sublease Income Increase (Decrease) In Deferred Sublease Income Other income (expense) Other Nonoperating Income (Expense) Entity Filer Category Entity Filer Category Statement [Table] Statement [Table] Contingent earnout liability Business Combination, Contingent Consideration, Liability, Noncurrent Current Fiscal Year End Date Current Fiscal Year End Date 2016 Stock Incentive Plan 2016 Stock Incentive Plan [Member] 2016 Stock Incentive Plan Percentage of concentration Concentration Risk, Percentage Estimated dividend yield Measurement Input, Expected Dividend Rate [Member] Beginning balance Ending balance Fair Value, Measurement with Unobservable Inputs Reconciliation, Recurring Basis, Liability Value Preferred stock, shares authorized (in shares) Preferred Stock, Shares Authorized Fair Value, Assets Measured on Recurring Basis, Unobservable Input Reconciliation [Line Items] Fair Value, Assets Measured on Recurring Basis, Unobservable Input Reconciliation [Line Items] Preferred stock, shares outstanding (in shares) Preferred Stock, Shares Outstanding ROU assets obtained in exchange for operating lease obligations (including remeasurement of ROU and lease liabilities due to changes in the timing of receipt of lease incentives) Right-of-Use Asset Obtained in Exchange for Operating Lease Liability, Net of Adjustments Right-of-Use Asset Obtained in Exchange for Operating Lease Liability, Net of Adjustments Net cash from operating activities Net Cash Provided by (Used in) Operating Activities Vested and exercisable, aggregate intrinsic value Share-Based Compensation Arrangement by Share-Based Payment Award, Options, Exercisable, Intrinsic Value Class of Stock [Axis] Class of Stock [Axis] Contract asset Contract with Customer, Asset, before Allowance for Credit Loss Other accrued expenses Other Accrued Liabilities, Current Accounts payable Disposal Group, Including Discontinued Operation, Accounts Payable Furniture and fixtures Furniture and Fixtures [Member] Lease Contractual Term [Domain] Lease Contractual Term [Domain] Statement of Financial Position [Abstract] Gain on disposal of business Gain (Loss) on Disposition of Business GeneFab GeneFab [Member] GeneFab Total stockholders’ equity Beginning balance Ending balance Equity, Attributable to Parent Current assets of discontinued operations Total current assets of discontinued operations Disposal Group, Including Discontinued Operation, Assets, Current Commercial Paper Commercial Paper [Member] Common stock subject to repurchase Common Stock Subject to Repurchase, Value Common Stock Subject to Repurchase, Value Maturities of short-term investments Proceeds from Maturities, Prepayments and Calls of Short-Term Investments Schedule of Share-Based Compensation Arrangements by Share-Based Payment Award [Table] Schedule of Share-Based Compensation Arrangements by Share-Based Payment Award [Table] Fair Value Measurement Inputs and Valuation Techniques Fair Value Measurement Inputs and Valuation Techniques [Table Text Block] Revenue recognized during period previously included in deferred revenue Contract with Customer, Liability, Revenue Recognized Schedule of Stock by Class [Table] Schedule of Stock by Class [Table] Option, maximum worth Option Indexed to Issuer's Equity, Shares, Value Option Indexed to Issuer's Equity, Shares, Value Concentration Risk Type [Axis] Concentration Risk Type [Axis] Expected term (in years) Share-Based Compensation Arrangement by Share-Based Payment Award, Fair Value Assumptions, Expected Term Subsequent Events [Abstract] Fair Value, Assets Measured on Recurring Basis, Unobservable Input Reconciliation [Table] Fair Value, Assets Measured on Recurring Basis, Unobservable Input Reconciliation [Table] Long-Lived Tangible Asset [Axis] Long-Lived Tangible Asset [Axis] Preferred stock, shares issued (in shares) Preferred Stock, Shares Issued Conversion of redeemable convertible preferred stock into common stock in connection with the Reverse Recapitalization, net of transaction costs (in shares) Stock Issued During Period, Shares, Conversion of Convertible Securities Level 2 Fair Value, Inputs, Level 2 [Member] Annual maintenance payments Collaborative Arrangement, Rights And Obligations, Contractual Annual Payments Collaborative Arrangement, Rights And Obligations, Contractual Annual Payments Entity Emerging Growth Company Entity Emerging Growth Company Customer B Customer B [Member] Customer B Estimated fair value of the shares on the date of grant (in percent) Share-Based Compensation Arrangement By Share-Based Payment Award, Exercise Price, Percentage Of Fair Market Value Share-Based Compensation Arrangement By Share-Based Payment Award, Exercise Price, Percentage Of Fair Market Value Continuing Operations Continuing Operations [Member] Disposal Group Classification [Domain] Disposal Group Classification [Domain] Increase (Decrease) in Stockholders' Equity [Roll Forward] Increase (Decrease) in Stockholders' Equity [Roll Forward] Common Stock Purchase Agreement Common Stock Purchase Agreement [Member] Common Stock Purchase Agreement Document Fiscal Period Focus Document Fiscal Period Focus 2024 Lessee, Operating Lease, Liability, to be Paid, Year One Accrued expenses and other current liabilities Increase (Decrease) in Accrued Liabilities and Other Operating Liabilities Antidilutive Securities [Axis] Antidilutive Securities [Axis] Unvested early exercised common stock Share-Based Payment Arrangement [Member] 2027 Lessee, Operating Lease, Liability, to be Paid, Year Four Outstanding, beginning of period (in dollars per share) Outstanding, end of period (in dollars per share) Share-Based Compensation Arrangement by Share-Based Payment Award, Options, Outstanding, Weighted Average Exercise Price Stock-based compensation expense Share-Based Payment Arrangement, Noncash Expense Tenant improvement allowance utilized Tenant Improvement Allowance Utilized Tenant Improvement Allowance Utilized Common Stock Common Stock [Member] Conversion of redeemable convertible preferred stock into common stock in connection with the Reverse Recapitalization, net of transaction cost Temporary Equity, Value, Conversion Of Convertible Securities Temporary Equity, Value, Conversion Of Convertible Securities Proceeds from issuance of common stock under Employee Stock Purchase Plan (ESPP) Proceeds from Issuance of Convertible Preferred Stock City Area Code City Area Code Entity Address, Postal Zip Code Entity Address, Postal Zip Code Product and Service [Axis] Product and Service [Axis] Net Loss Per Share Earnings Per Share [Text Block] Income Statement Location [Domain] Income Statement Location [Domain] Number of tranches Share-Based Compensation Arrangement By Share-Based Payment Award, Award Vesting Rights, Number Of Tranches Share-Based Compensation Arrangement By Share-Based Payment Award, Award Vesting Rights, Number Of Tranches Revenue From and Not From Contracts [Abstract] Revenue From and Not From Contracts Summary of Changes in Fair Value of Level 3 Financial Instruments Fair Value, Liabilities Measured on Recurring Basis, Unobservable Input Reconciliation [Table Text Block] Document Fiscal Year Focus Document Fiscal Year Focus Operating lease, term of contract Lessee, Operating Lease, Term of Contract Minimum Minimum [Member] Property and equipment, net Property and equipment, net Property, Plant and Equipment, Net GeneFab receivable - related party, net of current portion Accounts Receivable, after Allowance for Credit Loss, Noncurrent Share-Based Payment Arrangement, Option, Activity Share-Based Payment Arrangement, Option, Activity [Table Text Block] Cash and cash equivalents and debt securities, available-for-sale, adjusted cost Cash, Cash Equivalents, Restricted Cash And Debt Securities, Available For-Sale, Amortized Cost Cash, Cash Equivalents, Restricted Cash And Debt Securities, Available For-Sale, Amortized Cost Cash Cash Disposal Group Classification [Axis] Disposal Group Classification [Axis] Statement of Cash Flows [Abstract] Cash dividends declared and paid, common stock Dividends, Common Stock, Cash Assets Assets [Abstract] GeneFab sublease deferred income - related party Deferred Sublease Income Deferred Sublease Income Operating lease liabilities Increase (Decrease) in Operating Lease Liability Nonrelated Party Nonrelated Party [Member] Restricted cash Restricted Cash [Member] Restricted Cash Sublease income to be earned Lessor, Operating Lease, Sublease Payments To Be Received Lessor, Operating Lease, Sublease Payments To Be Received Long-Term Purchase Commitment [Line Items] Long-Term Purchase Commitment [Line Items] U.S. Treasury securities US Treasury Securities [Member] Net cash from financing activities Net Cash Provided by (Used in) Financing Activities Lessee, Lease, Description [Line Items] Lessee, Lease, Description [Line Items] Commitments and Contingencies Commitments and Contingencies Disclosure [Text Block] Net loss per share from continuing operations, diluted (in dollars per share) Income (Loss) from Continuing Operations, Per Diluted Share Operating cash flows net inflows and (outflows) from operating lease Operating Lease, Proceeds (Payments) Operating Lease, Proceeds (Payments) Accumulated Deficit Retained Earnings [Member] Unvested early exercised options Unvested Early Exercised Options [Member] Unvested Early Exercised Options Share-Based Payment Arrangement, Expensed and Capitalized, Amount Share-Based Payment Arrangement, Expensed and Capitalized, Amount [Table Text Block] Accretion of discount on short-term investments Accretion (Amortization) of Discounts and Premiums, Investments Total liabilities and stockholders’ equity Liabilities and Equity Adjusted Cost Debt Securities, Available-for-Sale, Amortized Cost Other income (expense) Nonoperating Income (Expense) [Abstract] Other long-term assets Other Assets, Noncurrent Risk-free interest rate (in percent) Share-Based Compensation Arrangement by Share-Based Payment Award, Fair Value Assumptions, Risk Free Interest Rate Net loss per share, basic (in dollars per share) Net loss per share attributable to common stockholders, basic (in shares) Earnings Per Share, Basic Operating lease right-of-use assets Operating Lease, Right-of-Use Asset Cost not yet recognized, options Share-Based Payment Arrangement, Nonvested Award, Option, Cost Not yet Recognized, Amount Issuance of common stock under Employee Stock Purchase Plan (ESPP) Stock Issued During Period, Value, Employee Stock Purchase Plan Equity Option Equity Option [Member] Accounting Policies [Abstract] Sale of Stock [Domain] Sale of Stock [Domain] Cancellation and exchange of convertible note in connection with PIPE financing Stock Issued During Period, Value, Cancellation And Exchange Of Convertible Debt Stock Issued During Period, Value, Cancellation And Exchange Of Convertible Debt Aggregate intrinsic value of options exercised Share-Based Compensation Arrangement by Share-Based Payment Award, Options, Exercises in Period, Intrinsic Value 2023, for the remainder of the year Lessee, Operating Lease, Liability, to be Paid, Remainder of Fiscal Year Entity Address, City or Town Entity Address, City or Town Related Party Related Party [Member] Discontinued Operations, Disposed of by Sale Discontinued Operations, Disposed of by Sale [Member] Proceeds from Merger and related PIPE financing, net of transaction costs Proceeds from Merger and Related PIPE Financing, Net of Transaction Costs Proceeds from Merger and Related PIPE Financing, Net of Transaction Costs Purchases of property and equipment Discontinued Operation, Payments to Acquire Property, Plant, and Equipment Discontinued Operation, Payments to Acquire Property, Plant, and Equipment Early exercise liability, net of current portion Early Exercise Liability, Noncurrent Early Exercise Liability, Noncurrent Schedule of Business Acquisitions by Acquisition, Contingent Consideration Schedule of Business Acquisitions by Acquisition, Contingent Consideration [Table Text Block] Document Transition Report Document Transition Report Fair Value Option Fair Value of Financial Instruments, Policy [Policy Text Block] Revenue, remaining performance obligation, variable consideration, percentage of realized gains Revenue, Remaining Performance Obligation, Variable Consideration, Percentage Of Realized Gains Revenue, Remaining Performance Obligation, Variable Consideration, Percentage Of Realized Gains Accounts payable Increase (Decrease) in Accounts Payable Common stock, shares authorized (in shares) Common Stock, Shares Authorized Derivative liability, measurement input Derivative Liability, Measurement Input Estimated Fair Value Debt Securities, Available-for-Sale Vesting of early exercise of common stock options (in shares) Stock Issued During Period, Shares, Vesting Of Early Exercise Of Stock Options Stock Issued During Period, Shares, Vesting Of Early Exercise Of Stock Options Exercises during the period (in shares) Share-Based Compensation Arrangement by Share-Based Payment Award, Non-Option Equity Instruments, Exercised Unrealized Gain Debt Securities, Available-for-Sale, Accumulated Gross Unrealized Gain, before Tax Short-term investments Short-Term Investments [Member] Derivative Instrument [Axis] Derivative Instrument [Axis] Common Stock Purchase Agreement fee settled in common stock Stock Issued During Period, Value, Purchase Agreement Fee Settled In Stock Stock Issued During Period, Value, Purchase Agreement Fee Settled In Stock Equity Plans Common Stock Under Equity Plans [Member] Common Stock Under Equity Plans Liability Class [Axis] Liability Class [Axis] Related Party Transactions [Abstract] Measurement Input Type [Axis] Measurement Input Type [Axis] Notes Receivable Notes Receivable [Member] Corporate Headquarters Corporate Headquarters [Member] Corporate Headquarters Additional paid-in capital Additional Paid in Capital Research and Development Arrangement Research and Development Arrangement [Member] Forfeited (in dollars per share) Share-Based Compensation Arrangement by Share-Based Payment Award, Equity Instruments Other than Options, Forfeitures, Weighted Average Grant Date Fair Value May 2022 Note May 2022 Note [Member] May 2022 Note Subsequent Event Type [Axis] Subsequent Event Type [Axis] Proceeds from issuance of common stock upon exercise of stock options Proceeds from Stock Options Exercised Derivative Financial Instruments, Liabilities Derivative Financial Instruments, Liabilities [Member] Contingent Consideration, Tranche Two Contingent Consideration, Tranche Two [Member] Contingent Consideration, Tranche Two Share-Based Payment Arrangement, Expensed and Capitalized, Amount [Table] Share-Based Payment Arrangement, Expensed and Capitalized, Amount [Table] Market Awards Market Awards [Member] Market Awards Forfeited (in dollars per share) Share-Based Compensation Arrangements by Share-Based Payment Award, Options, Forfeitures in Period, Weighted Average Exercise Price Prepaid expenses and other current assets Prepaid expenses and other current assets Prepaid Expense and Other Assets, Current Forfeited (in shares) Share-Based Compensation Arrangement by Share-Based Payment Award, Equity Instruments Other than Options, Forfeited in Period Gain on disposal of business Gain on disposal of business Discontinued Operation, Gain (Loss) on Disposal of Discontinued Operation, Net of Tax Number of seats on the board of directors Number of Seats On The Board Of Directors Number of Seats On The Board Of Directors Common stock share price (in dollars per share) Share Price Related Party [Axis] Related Party, Type [Axis] Outstanding, beginning of period, aggregate intrinsic value Outstanding, end of period, aggregate intrinsic value Share-Based Compensation Arrangement by Share-Based Payment Award, Options, Outstanding, Intrinsic Value Document preparation fees Sale Of Stock, Document Preparation Fees Sale Of Stock, Document Preparation Fees Contingent Earnout Liability Contingent Earnout Liability [Member] Contingent Earnout Liability Option, exercise term (in months) Option Indexed to Issuer's Equity, Exercise Term Option Indexed to Issuer's Equity, Exercise Term Closing stock price to trigger contingent earnout shares (in dollars per share) Reverse Recapitalization, Contingent Consideration, Equity, Earnout Period, Stock Price Trigger Reverse Recapitalization, Contingent Consideration, Equity, Earnout Period, Stock Price Trigger Common Stock Purchase Agreement fee settled in common stock (in shares) Stock Issued During Period, Shares, Purchase Agreement Fee Settled In Stock Stock Issued During Period, Shares, Purchase Agreement Fee Settled In Stock Entity Registrant Name Entity Registrant Name Change in fair value of contingent earnout liability Change in fair value of contingent earnout liability Gain (loss) on change in fair value of contingent earnout liability Business Combination, Contingent Consideration Arrangements, Change in Amount of Contingent Consideration, Liability Lease Contractual Term [Axis] Lease Contractual Term [Axis] Document Period End Date Document Period End Date Less: accumulated depreciation Accumulated Depreciation, Depletion and Amortization, Property, Plant, and Equipment Disposal Group Name [Axis] Disposal Group Name [Axis] Vested and exercisable (in shares) Share-Based Compensation Arrangement by Share-Based Payment Award, Options, Exercisable, Weighted Average Exercise Price Finance lease liabilities, net of current portion Finance Lease, Liability, Noncurrent Entity Central Index Key Entity Central Index Key Prepayments for manufacturing and research activities Prepaid Expense Change in fair value included in other income (expense) Fair Value, Measurement with Unobservable Inputs Reconciliation, Recurring Basis, Asset, Gain (Loss) Included in Earnings Total stock-based compensation expense Share-Based Payment Arrangement, Expense Income tax provision (benefit) Income Tax Expense (Benefit) Outstanding, end of period, weighted average remaining contractual life (in years) Share-Based Compensation Arrangement by Share-Based Payment Award, Equity Instruments Other than Options, Outstanding, Weighted Average Remaining Contractual Terms Disposal Group, Including Discontinued Operation, Income Statement Disclosures [Abstract] Disposal Group, Including Discontinued Operation, Income Statement Disclosures [Abstract] Accrued employee-related expenses Employee-related Liabilities, Current Fair Value Measurements Fair Value Disclosures [Text Block] Revenue Benchmark Revenue Benchmark [Member] Bayer Bayer [Member] Bayer Issuance of common stock upon Reverse Recapitalization, net of transaction costs Stock Issued During Period, Value, New Issues Equity [Abstract] Debt Securities, Available-for-Sale [Line Items] Debt Securities, Available-for-Sale [Line Items] Weighted-average remaining lease term Operating Lease, Weighted Average Remaining Lease Term Number of business activities Number of Business Activities Number of Business Activities GeneFab Economic Share - related party Contingent Consideration Receivable Contingent Consideration Receivable Contract revenue Revenue from Contract with Customer, Excluding Assessed Tax Exercise price of an ISO granted to a stockholder (in percent) Share-Based Compensation Arrangement By Share-Based Payment Award, Stockholder Ownership Percentage, Threshold Share-Based Compensation Arrangement By Share-Based Payment Award, Stockholder Ownership Percentage, Threshold Amendment Flag Amendment Flag Beginning balance (in shares) Ending balance (in shares) Temporary Equity, Shares Outstanding 2025 Lessor, Operating Lease, Payment to be Received, Year Two Money market funds Money Market Funds [Member] Cash and cash equivalents Cash and Cash Equivalents, at Carrying Value Weighted-average discount rate Operating Lease, Weighted Average Discount Rate, Percent Issued in period (in shares) Share-Based Compensation Arrangement by Share-Based Payment Award, Shares Issued in Period Fair value Property, Plant, and Equipment, Fair Value Disclosure GeneFab Notes Receivable GeneFab Notes Receivable [Member] GeneFab Notes Receivable Sublease Rent Sublease Rent [Member] Sublease Rent Tenant improvement allowance Tenant Improvement Allowance Tenant Improvement Allowance Current liabilities of discontinued operations Total current liabilities of discontinued operations Disposal Group, Including Discontinued Operation, Liabilities, Current Contingent Consideration Type [Domain] Contingent Consideration Type [Domain] Leasehold improvements Leasehold Improvements [Member] Option, exercise price (in dollars per share) Option Indexed to Issuer's Equity, Strike Price Weighted-average shares outstanding, diluted (in shares) Weighted-average shares used in computing net loss per share, diluted (in shares) Weighted Average Number of Shares Outstanding, Diluted Prepaid expenses and other current assets Disposal Group, Including Discontinued Operation, Prepaid and Other Assets, Current Tenant improvement allowance received Tenant Improvement Reimbursements Tenant Improvement Reimbursements Contingent Consideration Tranches [Domain] Contingent Consideration Tranches [Domain] Contingent Consideration Tranches [Domain] Disposal Groups, Including Discontinued Operations Disposal Groups, Including Discontinued Operations [Table Text Block] Celest Therapeutics (Shanghai) Co. Ltd. Celest Therapeutics (Shanghai) Co. Ltd. [Member] Celest Therapeutics (Shanghai) Co. Ltd. Interest income, net Interest Income (Expense), Nonoperating, Net Operating expenses Operating Expenses [Abstract] Variable sublease income Operating Lease, Variable Lease Income Purchases of property and equipment Payments to Acquire Property, Plant, and Equipment Additional Paid-in Capital Additional Paid-in Capital [Member] Balance Sheet Location [Axis] Balance Sheet Location [Axis] Research and development Disposal Group, Including Discontinued Operation, Research And Development Expense Disposal Group, Including Discontinued Operation, Research And Development Expense Total assets Assets Number of tranches of contingent earnout shares Reverse Recapitalization, Contingent Consideration, Equity, Number of Tranches Reverse Recapitalization, Contingent Consideration Classified as Equity, Number of Tranches Cover [Abstract] Category of Item Purchased [Axis] Category of Item Purchased [Axis] Subsequent Events Subsequent Events [Text Block] Proceeds from issuance of convertible notes Proceeds from Convertible Debt Stock-based compensation expense APIC, Share-Based Payment Arrangement, Increase for Cost Recognition Noncurrent assets of discontinued operations Total non-current assets of discontinued operations Disposal Group, Including Discontinued Operation, Assets, Noncurrent Grant income Grant [Member] Threshold of years for change of control (in years) Reverse Recapitalization, Contingent Consideration, Equity, Threshold of Years for Change of Control Reverse Recapitalization, Contingent Consideration, Equity, Threshold of Years for Change of Control Fair Value Measurement Inputs and Valuation Techniques [Line Items] Fair Value Measurement Inputs and Valuation Techniques [Line Items] Vested and exercisable, end of period (in dollars per share) Share-Based Compensation Arrangement by Share-Based Payment Award, Equity Instruments Other than Options, Vested in Period, Weighted Average Grant Date Fair Value Total undiscounted lease payments Total undiscounted lease payments Lessee, Operating Lease, Liability, to be Paid Consideration received in collaborative development agreement Revenue, Remaining Performance Obligation, Amount Short-term investments Short-Term Investments Construction in progress Construction in Progress [Member] Extension of term of contract (in months) Contract With Customer, Extension Of Term, Modification Of Contract Contract With Customer, Extension Of Term, Modification Of Contract Total operating expenses Operating Expenses Net decrease in cash and cash equivalents Cash, Cash Equivalents, Restricted Cash, and Restricted Cash Equivalents, Period Increase (Decrease), Including Exchange Rate Effect Cash flows from financing activities Net Cash Provided by (Used in) Financing Activities [Abstract] Lease renewal term Lessee, Operating Lease, Renewal Term Equity Component [Domain] Equity Component [Domain] Lab equipment Laboratory Equipment [Member] Laboratory Equipment Finance lease liabilities, current portion Finance Lease, Liability, Current Percent of outstanding shares Share-Based Compensation Arrangement by Share-Based Payment Award, Purchase Price of Common Stock, Percent Cancellation and exchange of convertible note in connection with PIPE financing (in shares) Stock Issued During Period, Shares, Cancellation And Exchange Of Convertible Debt Stock Issued During Period, Shares, Cancellation And Exchange Of Convertible Debt Weighted-average shares outstanding, basic (in shares) Weighted-average shares used in computing net loss per share, basic (in shares) Weighted Average Number of Shares Outstanding, Basic Entity Current Reporting Status Entity Current Reporting Status Concentration Risk Type [Domain] Concentration Risk Type [Domain] Loss from operations Operating Income (Loss) Concentration Risk Benchmark [Axis] Concentration Risk Benchmark [Axis] NEA NEA [Member] NEA ESPP purchase price of common stock, percent of market price (in percent) Share-Based Compensation Arrangement, By Share-Based Payment Award, Annual Increase In Shares Authorized, Percentage Of Outstanding Shares Share-Based Compensation Arrangement, By Share-Based Payment Award, Annual Increase In Shares Authorized, Percentage Of Outstanding Shares Revenue Revenues [Abstract] Cash and cash equivalents Cash and Cash Equivalents [Member] Term of agreement Sale Of Stock, Term Of Agreement Sale Of Stock, Term Of Agreement Accrued expenses and other current liabilities Disposal Group, Including Discontinued Operation, Accrued Expenses And Other Current Liabilities Disposal Group, Including Discontinued Operation, Accrued Expenses And Other Current Liabilities Sublease income, including variable costs Operating Lease, Lease Income Related Party Transaction [Axis] Related Party Transaction [Axis] Statement [Line Items] Statement [Line Items] Conversion of redeemable convertible preferred stock into common stock in connection with the Reverse Recapitalization, net of transaction cost Stock Issued During Period, Value, Conversion of Convertible Securities Concentration Risk [Table] Concentration Risk [Table] Other comprehensive loss Other Comprehensive Income (Loss), Net of Tax [Abstract] Common stock subject to repurchase (in shares) Weighted Average Number of Shares, Common Stock Subject to Repurchase or Cancellation Stock Options Additional Disclosures Share-Based Compensation Arrangement by Share-Based Payment Award, Options, Additional Disclosures [Abstract] Agreement evaluation period Revenue from Contract with Customer, Evaluation Period Revenue from Contract with Customer, Evaluation Period Non-Oncology Business Non-Oncology Business [Member] Non-Oncology Business GeneFab Option GeneFab Option [Member] GeneFab Option Net income (loss) from discontinued operations Net income (loss) from discontinued operations Income (Loss) from Discontinued Operations, Net of Tax, Attributable to Parent